Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Gilenya is used to treat Multiple Sclerosis (MS) and works to decrease the frequency of relapse symptoms. It is an immunosuppressant that keeps immune cells trapped in the lymph nodes so they cannot reach the central nervous system. Since its approval in 2010, Gilenya has been used by more than 30,000 people worldwide. In one year, sales for Gilenya were $291 million.
One of the known side effects of Gileyna is bradycardia, a slowed heart rate that is thought to return to normal after stopping taking the drug.
In 2011, the FDA announced that it was investigating deaths that were thought to have been caused by Gilenya. In 2012, the European Medicines Agency also announced that it was investigating the drug. Both agencies had reports of patients dying after their first dose of Gilenya. One patient died within 24 hours of receiving the drug, while the manufacturer, Novartis AG, confirmed that 10 more deaths had occurred in Gilenya patients; six of these fatalities were unexplained, three were caused by heart attack and one was cause by a disruption of heart rhythm.
It is now advised the doctors monitor patients after being administered Gileyna, and to perform an echocardiogram before and after to ensure heart health. Doctors were also advised to monitor blood pressure and heart rate.
Serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.